Market Highlights:

It is estimated that the global microbiome sequencing services market is expected to register a CAGR 19.22% during the forecast period of 2018–2023, with an estimated market value of USD 555.1 million in 2017.

The global Microbiome Sequencing Services Market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in November 2017, Microbiome Therapeutics, LLC launched the first microbiome modulator. This product is a natural blend of prebiotics manufactured to help nurture and nourish beneficial microorganisms in the lower gut. Also, in January 2018, Illumina launched BaseSpace Sequence in China. It is a cloud-based solution used for genomic data storage and analysis of samples.

Numerous factors such as high investment in next-generation sequencing, rising genome mapping programs in various countries, and the demand for microbiome research is anticipated to fuel the growth of the market. Moreover, the increasing investments in next-generation sequencing by various public and private organizations have created a lucrative option for many companies to invest in providing microbiome sequencing services, leading to the overall growth of the market. For instance, according to the data published by the Wall Street Journal in 2016, reported that venture funding in microbiome firms raised by 458.5% to USD 114.5 million from 2011 to 2015.

Key Players:

• Metabiomics Corp
• Baseclear B.V
• Clinical Microbiomics A/S
• EPIBIOME
• Merieux Nutrisciences Corporation
• Microbiome Insights Inc
• Microbiome Therapeutics
• MR DNA
• Rancho Biosciences
• Second Genome
• Ubiome, Inc
• Zymo Research Corp

Segmentation

• The global microbiome sequencing services market has been segmented into technology, application, and end user.
• The market, based on technology, has been segmented into Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), short gun sequencing, targeted gene sequencing, RNA sequencing, and others.
• The market, by application, has been further segmented into gastrointestinal diseases, infectious diseases, CNS diseases, oncology, and others.
• The market, by end user, has been segmented into research and academic institutes, pharmaceutical and biotechnology companies, and others.

Regional Analysis

The market in the Americas is expected to dominate the global microbiome sequencing services market during the forecast period owing to the increasing per capita healthcare expenditure, and the heavy adoption of new technology in the region. Europe is expected to hold the second largest position in the global microbiome sequencing services market. The market growth in this region is because of the presence of a well-established healthcare system and increase in life-threatening diseases. For instance, according to cancer research UK, there were approximately 9, 921 cases of cancer diagnosed in 2015. Such high rates of cancer are likely to increase demand for use of next-generation sequencing as well as increase the market demands for monoclonal bodies and cellular research. These factors are expected to have a positive impact on the microbiome sequencing services market. Asia-Pacific is estimated to be the fastest growing region in the market due to the huge patient pool of chronic diseases and government initiatives of healthcare reforms. The market in the Middle East & Africa is likely to account for the smallest share of the global microbiome sequencing services market. The market growth in this region owes to the low disposable income in the region.

29 May 2019, The global microbiome sequencing services market is estimated to develop by a substantial CAGR of 22.10% for the duration of the prediction. The progress of this market is boosted by the upsurge in usage of microbiomes in technical, proteomics, metabolomics, and genomics progressions in Next-Generation Sequencing [NGS]. Then again, absence of lawful & principled matters, thorough investigation and government guidelines associated with NGS are the most important issues driving the development of market of microbiome sequencing services.

The microbiome sequencing services market on the source of Type of End user could span Biotechnology & Medicinal Companies, Research Institutions, and Academic Institutions. The subdivision of Biotechnology & Medicinal Companies is projected to develop at the maximum CAGR in the market for the duration of past year. The Biotechnology & Medicinal Companies were the most important end-users to this market for microbiome sequencing services for the duration of recent past year.

The market research experts have forecast that although the influence of this subdivision on the progress of the market will drop in the approaching years, it will continue to constitute the supreme stake of the market for microbiome sequencing services during the course of the prediction. The market on the source of Type of Laboratory could span Dry Lab, Wet Lab. The subdivision of Wet Laboratory grasped the utmost CAGR in the market during the in past year.

The market on the source of Type of Research could span Internal Research and Subcontracted Research. The subdivision of Subcontracted Research is estimated to grasp the maximum CAGR along with the main stake of the market during the past year. This CAGR and the biggest stake could be credited to the growing subcontracting the actions of Research & Development.

The market on the source of Type of Application could span Whole Genome Sequencing, Targeted Gene Sequencing, RNA Sequencing and Shotgun Sequencing. The other applications consist of Protein Analysis, Small Molecule Analysis. The subdivision of Shotgun Sequencing is expected to develop at the maximum CAGR and hold the utmost stake of the market for the duration of the prediction.

Get Sample Copy of this Report @

https://www.millioninsights.com/industry-reports/microbiome-sequencing-services-market/request-sample

The microbiome sequencing services market on the source of Type of Technology could span Sanger Sequencing, Sequencing by Ligation [SBL], Pyrosequencing, Sequencing by Synthesis [SBS] and the other technologies (Omics Technologies).

The microbiome sequencing services market on the source of Area with respect to Trades in terms of intake, Profits, Market stake, and Development percentage in these areas for the duration of the prediction could span North America, Europe, Asia Pacific, and Middle East Asia & Africa.

By the source of geography, the Americas were responsible for the supreme stake of the market for the duration of the recent past year. The development of the market in this area is largely owing to the enormous funds put in the research of healthcare. Furthermore, the existence of the finance assistances in the U.S.A, impelling progresses in the research of life science. Likewise considerably funds to the development of the market of microbiome sequencing services in this area.

The statement revises Trades in terms of intake of microbiome sequencing services in the market; particularly in North America, Europe, Asia Pacific, and Middle East Asia & Africa. It concentrates on the topmost companies operating in these regions. Some of the important companies operating in the field are Second Genome, Diversigen Inc., BGI, GATC Biotech and Clinical-Microbiomics.

The additional notable companies operating in the field are- Molecular Research LP, Molzym GmbH and Co. KG, Metabiomics Corp., Microbiome Insights Inc., Ubiome Inc., Rancho Biosciences, Merieux Nutrisciences Corporation, Zymo Research Corp.,and Microbiome Therapeutics LLC.

Browse Related Category Market Reports @

https://www.millioninsights.com/industry/biotechnology